Abstract
Ezetimibe / simvastatin is a combination of two fixed-dose drugs authorized for complementary treatment of hypercholesterolemia or hyperlipidemia in patients not adequately controlled with a statin alone. It is also indicated to reduce cardiovascular events in patients with a history of coronary heart disease
Keywords
Ezetimibe; Hyperlipidemia; Cardiovascular events
Bibliographic citation
Ezetimiba/simvastatina: Tractament complementari a la dieta en pacients amb hipercolesterolèmia primària. Barcelona: Servei Català de la Salut; 2017.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/3512This item appears in following collections
The following license files are associated with this item: